AJP - GI Fuel your research with LabChart
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Am J Physiol Gastrointest Liver Physiol 294: G1235-G1244, 2008. First published March 6, 2008; doi:10.1152/ajpgi.00037.2008
0193-1857/08 $8.00
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
294/5/G1235    most recent
00037.2008v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Google Scholar
Right arrow Articles by Natarajan, G.
Right arrow Articles by Anant, S.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Natarajan, G.
Right arrow Articles by Anant, S.

MUCOSAL BIOLOGY

CUGBP2 downregulation by prostaglandin E2 protects colon cancer cells from radiation-induced mitotic catastrophe

Gopalan Natarajan,1 Satish Ramalingam,1 Ilangovan Ramachandran,2 Randal May,1 Lurdes Queimado,2,3 Courtney W. Houchen,1,4,5 and Shrikant Anant1,3,4

Departments of 1Medicine, 2Otorhinolaryngology, and 3Cell Biology, and 4OU Cancer Institute, University of Oklahoma Health Sciences Center, Oklahoma City; and 5Department of Veteran Affairs Medical Center, Oklahoma City, Oklahoma

Submitted 24 January 2008 ; accepted in final form 2 March 2008

Prostaglandin E2 (PGE2) is a potent inhibitor of ionizing radiation (IR)-induced cell death. Exposure of colon cancer cells to IR leads to increased CUGBP2 expression. Therefore, we tested the hypothesis that PGE2 radioprotects colon cancer cells by inhibiting CUGBP2 expression. Exposure of HCT-116 cells to {gamma}-IR (0–12 Gy) resulted in a dose-dependent reduction in cell growth and an increase in the G2-M phase of the cell cycle. Western blot analyses demonstrated increased levels of activated caspase 9 and caspase 3. In addition, whereas Bax expression is increased, that of Bcl-2 and Bcl-xL was reduced. Further analyses demonstrated increased activation of Chk1 and Chk2 kinases, coupled with higher levels of nuclear cyclin B1 and Cdc2. Pretreatment with PGE2 suppressed the activation of caspase 3 and caspase 7 and inhibited Bax expression. In addition, PGE2 treatment restored growth and colony formation to control levels. IR significantly upregulated the expression of CUGBP2 in the cells, which was suppressed when cells were pretreated with PGE2. Ectopic overexpression of CUGBP2 also induced apoptosis. Furthermore, it reversed the PGE2-mediated protection from IR-induced mitotic catastrophe. Furthermore, there was an increase in nuclear localization of cyclin B1 and Cdc2 coupled with increased phosphorylation of p53, Chk1, Chk2, and Cdc25c proteins. Cell cycle analysis also demonstrated increased G2-M transition. In contrast, siRNA-mediated suppression of CUGBP2 expression restored normal cell cycle progression and decreased IR-induced apoptosis. Taken together, these data demonstrate that PGE2 protects colon cancer cells from IR-induced mitotic catastrophe in part through suppression of CUGBP2 expression.

cell cycle; apoptosis; caspase; check point kinases; RNA binding protein



Address for reprint requests and other correspondence: S. Anant, Dept. of Medicine, Univ. of Oklahoma Health Sciences Center, 920 Stanton L. Young Blvd., WP1360, Oklahoma City, OK 73104 (e-mail: shrikant-anant{at}ouhsc.edu)







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online
Copyright © 2008 by the American Physiological Society.